Infectious Diseases
Page 1 • 3 itemsGlobal pharma infectious disease market intelligence: track R&D, regulatory approvals, and investment trends for novel antivirals, antibacterials, and vaccines.
GHIT Fund Invests $8.5 Million in Malaria and NTD Drug Development with GSK, Eisai Partners
GHIT Fund announces $8.5 million investment across five R&D projects for malaria and neglected tropical disease treatments with major pharma partners.
GHIT Fund Invests $8.5 Million in Malaria and Neglected Tropical Disease Drug Development with GSK, Eisai Partners
GHIT Fund announces $8.5M investment across five R&D projects targeting malaria and neglected tropical diseases with pharmaceutical partners.
Qdenga Dengue Vaccine Approved in Australia for Ages 4+ Against All Four Virus Serotypes
Australia's TGA approves Qdenga tetravalent dengue vaccine for protection against all four dengue virus serotypes in patients aged 4 years and older.